3.5 EUR
0.14
3.85%
Last update Dec 16, 8:13 AM CET
Market closed
Day range
3.5
3.5
Previous close
3.64000
Open
3.5
Access this stock data via API
Subscribe
Nervgen Pharma Corp.
3.50
0.14
3.85%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 2.8M 1.7M 1.9M 2.8M
Selling general and admin 1.1M 2.3M 1.8M 1.4M
Other operating expenses
Operating income -3.8M -4.0M -3.7M -4.2M
Non operating interest income
Income 47.7K 53.8K 66.7K 105.9K
Expense
Other income expense 1.2M -1.7M 1.2M -1.2M
Pretax income -2.6M -5.6M -2.4M -5.3M
Tax provision
Net income -2.6M -5.6M -2.4M -5.3M
Basic EPS -0.1 -0.1 -0.1
Diluted EPS -0.1 -0.1 -0.1
Basic average shares 45.3M 44.6M 43.8M
Diluted average shares 45.3M 44.6M 43.8M
EBITDA -5.0M -2.3M -5.0M -3.0M
Net income from continuing op. -2.6M -5.6M -2.4M -5.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 4 minutes

23:55
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).